Neuspera Medical

Neuspera Medical is a commercial-stage neurostimulation company that has developed a novel, integrated system for sacral neuromodulation (SNM) therapy. Its FDA-approved system for urinary urge incontinence (UUI) eliminates the need for a surgically replaced implanted battery by using patented Mid-Field Powering technology, where an external wearable wirelessly charges a smart, miniaturized implant. This patient-centered approach aims to reduce complications and improve the treatment experience while maintaining efficacy comparable to traditional SNM. The company positions its platform as the foundation for a new class of deep-body neurostimulation devices with potential applications beyond urology.

Patented Mid-Field Powering technology that uses evanescent and propagating electromagnetic waves to wirelessly power implanted medical devices at depths of 10cm+, using the body as a waveguide. This enables a battery-free implant paired with an external wearable, smartphone app, and clinician programmer.

Neuspera competes directly with established leaders in sacral neuromodulation, notably Medtronic with its InterStim systems and Axonics with its rechargeable r-SNM system. Competition is based on efficacy, device longevity/size, patient experience, and clinical support. Neuspera's key differentiator is its battery-free implant powered by an external wearable, aiming to offer a best-in-class patient experience without the need for future explant surgeries.